Related Experiment Video
Updated: Dec 11, 2025

10:42
A Free-breathing fMRI Method to Study Human Olfactory Function
Published on: July 30, 2017
10.0K
Olfactory dysfunction in frontotemporal dementia and psychiatric disorders: A systematic review
Sarah Ellen Carnemolla1, Julien Wen Hsieh2, Rebecca Sipione3
1The University of Sydney, Brain & Mind Centre, Sydney, Australia.
Neuroscience and Biobehavioral Reviews
|August 21, 2020
Summary
Olfactory dysfunction profiles can help differentiate frontotemporal dementia (FTD) from psychiatric disorders. Testing odour identification and discrimination shows distinct patterns in FTD versus depression and schizophrenia.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Neurology
Background:
- Frontotemporal dementia (FTD) diagnosis is challenging due to symptom overlap with psychiatric disorders like depression and schizophrenia.
- Olfactory dysfunction is a common early symptom in both FTD and psychiatric conditions, often preceding other clinical signs.
- Understanding smell dysfunction profiles may aid in differential diagnosis.
Purpose of the Study:
- To systematically review and analyze studies on olfactory function in FTD, depression, schizophrenia, and bipolar disorder.
- To identify distinct olfactory dysfunction profiles, specifically in odour identification and discrimination, across these conditions.
- To evaluate the utility of olfactory testing in differentiating FTD from psychiatric disorders.
Main Methods:
- Systematic review of 74 studies examining olfactory function (odour identification and discrimination) in FTD, depression, schizophrenia, and bipolar disorder.
- Comparative analysis of olfactory performance across patient groups.
- Focus on common smell assessment measures.
Main Results:
- Frontotemporal dementia patients exhibited severe odour identification deficits but intact odour discrimination.
- Schizophrenia patients showed impairments in both odour identification and discrimination.
- Depression patients displayed no significant olfactory impairments; bipolar disorder findings were mixed.
- Olfactory testing differentiated FTD from depression and schizophrenia, but not reliably from bipolar disorder.
Conclusions:
- Distinct olfactory dysfunction profiles, particularly in odour identification, can help distinguish frontotemporal dementia from depression and schizophrenia.
- Olfactory testing, specifically assessing odour identification and discrimination, offers a promising, non-invasive tool for improving differential diagnosis in neurodegenerative and psychiatric conditions.
- Further research is needed to clarify olfactory profiles in bipolar disorder for complete diagnostic differentiation.
Related Concept Videos
Olfaction
47.7K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
47.7K
Olfactory Receptors: Location and Structure
10.9K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
10.9K
Physiology of Smell and Olfactory Pathway
11.6K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
The olfactory...
11.6K
Taste Buds and Receptors
4.2K
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
4.2K
Dementia
413
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
413
Alzheimer's Disease: Overview
1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K

